ID   GGCT_HUMAN              Reviewed;         188 AA.
AC   O75223; B2RDN0; B8ZZN4; B8ZZR8; Q9BS37;
DT   22-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   10-MAY-2017, entry version 130.
DE   RecName: Full=Gamma-glutamylcyclotransferase;
DE            EC=2.3.2.4;
DE   AltName: Full=Cytochrome c-releasing factor 21;
GN   Name=GGCT; Synonyms=C7orf24, CRF21;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Kidney, Lung, Skin, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, AND INDUCTION.
RX   PubMed=16765912; DOI=10.1016/j.bbrc.2006.05.161;
RA   Masuda Y., Maeda S., Watanabe A., Sano Y., Aiuchi T., Nakajo S.,
RA   Itabe H., Nakaya K.;
RT   "A novel 21-kDa cytochrome c-releasing factor is generated upon
RT   treatment of human leukemia U937 cells with geranylgeraniol.";
RL   Biochem. Biophys. Res. Commun. 346:454-460(2006).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS), IDENTIFICATION BY MASS
RP   SPECTROMETRY, FUNCTION, SUBUNIT, ACTIVE SITE, AND MUTAGENESIS OF
RP   GLY-23; GLU-98; TYR-105 AND TYR-125.
RX   PubMed=18515354; DOI=10.1074/jbc.M803623200;
RA   Oakley A.J., Yamada T., Liu D., Coggan M., Clark A.G., Board P.G.;
RT   "The identification and structural characterization of C7orf24 as
RT   gamma-glutamyl cyclotransferase: an essential enzyme in the gamma-
RT   glutamyl cycle.";
RL   J. Biol. Chem. 283:22031-22042(2008).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.01 ANGSTROMS) OF 2-188, AND SUBUNIT.
RX   PubMed=17932939; DOI=10.1002/prot.21719;
RA   Bae E., Bingman C.A., Aceti D.J., Phillips G.N. Jr.;
RT   "Crystal structure of Homo sapiens protein LOC79017.";
RL   Proteins 70:588-591(2008).
CC   -!- FUNCTION: Catalyzes the formation of 5-oxoproline from gamma-
CC       glutamyl dipeptides and may play a significant role in glutathione
CC       homeostasis. Induces release of cytochrome c from mitochondria
CC       with resultant induction of apoptosis.
CC       {ECO:0000269|PubMed:16765912, ECO:0000269|PubMed:18515354}.
CC   -!- CATALYTIC ACTIVITY: (Gamma-L-glutamyl)-L-amino acid = 5-oxoproline
CC       + L-amino acid.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.0 mM for gamma-glutamyl-L-alanine;
CC         Vmax=50.3 umol/min/mg enzyme;
CC   -!- SUBUNIT: Homodimer. {ECO:0000305|PubMed:17932939,
CC       ECO:0000305|PubMed:18515354}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=O75223-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75223-2; Sequence=VSP_035599, VSP_035600;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=O75223-3; Sequence=VSP_046463;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on EST data.;
CC       Name=4;
CC         IsoId=O75223-4; Sequence=VSP_046464;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on EST data.;
CC   -!- INDUCTION: By geranylgeraniol. {ECO:0000269|PubMed:16765912}.
CC   -!- SIMILARITY: Belongs to the gamma-glutamylcyclotransferase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK315608; BAG37977.1; -; mRNA.
DR   EMBL; AC005154; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471073; EAW93950.1; -; Genomic_DNA.
DR   EMBL; CH471073; EAW93952.1; -; Genomic_DNA.
DR   EMBL; CH471073; EAW93953.1; -; Genomic_DNA.
DR   EMBL; BC000625; AAH00625.1; -; mRNA.
DR   EMBL; BC005356; AAH05356.1; -; mRNA.
DR   EMBL; BC013937; AAH13937.1; -; mRNA.
DR   EMBL; BC019243; AAH19243.1; -; mRNA.
DR   CCDS; CCDS5428.1; -. [O75223-1]
DR   CCDS; CCDS56474.1; -. [O75223-3]
DR   CCDS; CCDS56475.1; -. [O75223-2]
DR   CCDS; CCDS56476.1; -. [O75223-4]
DR   RefSeq; NP_001186744.1; NM_001199815.1. [O75223-4]
DR   RefSeq; NP_001186745.1; NM_001199816.1. [O75223-2]
DR   RefSeq; NP_001186746.1; NM_001199817.1. [O75223-3]
DR   RefSeq; NP_076956.1; NM_024051.3. [O75223-1]
DR   UniGene; Hs.530024; -.
DR   PDB; 2I5T; X-ray; 2.01 A; A/B=2-188.
DR   PDB; 2PN7; X-ray; 2.41 A; A/B=1-188.
DR   PDB; 2Q53; X-ray; 2.01 A; A/B=2-188.
DR   PDB; 2RBH; X-ray; 2.10 A; A/B=1-188.
DR   PDB; 3CRY; X-ray; 1.70 A; A/B=1-188.
DR   PDBsum; 2I5T; -.
DR   PDBsum; 2PN7; -.
DR   PDBsum; 2Q53; -.
DR   PDBsum; 2RBH; -.
DR   PDBsum; 3CRY; -.
DR   ProteinModelPortal; O75223; -.
DR   SMR; O75223; -.
DR   BioGrid; 122486; 10.
DR   IntAct; O75223; 7.
DR   STRING; 9606.ENSP00000275428; -.
DR   iPTMnet; O75223; -.
DR   PhosphoSitePlus; O75223; -.
DR   BioMuta; GGCT; -.
DR   OGP; O75223; -.
DR   EPD; O75223; -.
DR   MaxQB; O75223; -.
DR   PaxDb; O75223; -.
DR   PeptideAtlas; O75223; -.
DR   PRIDE; O75223; -.
DR   DNASU; 79017; -.
DR   Ensembl; ENST00000005374; ENSP00000005374; ENSG00000006625. [O75223-2]
DR   Ensembl; ENST00000275428; ENSP00000275428; ENSG00000006625. [O75223-1]
DR   Ensembl; ENST00000409144; ENSP00000386610; ENSG00000006625. [O75223-3]
DR   Ensembl; ENST00000409390; ENSP00000387235; ENSG00000006625. [O75223-4]
DR   GeneID; 79017; -.
DR   KEGG; hsa:79017; -.
DR   UCSC; uc003tba.4; human. [O75223-1]
DR   CTD; 79017; -.
DR   DisGeNET; 79017; -.
DR   GeneCards; GGCT; -.
DR   HGNC; HGNC:21705; GGCT.
DR   HPA; HPA020735; -.
DR   HPA; HPA029914; -.
DR   MIM; 137170; gene.
DR   neXtProt; NX_O75223; -.
DR   OpenTargets; ENSG00000006625; -.
DR   PharmGKB; PA162389392; -.
DR   eggNOG; KOG4059; Eukaryota.
DR   eggNOG; ENOG4111IGG; LUCA.
DR   GeneTree; ENSGT00500000044921; -.
DR   HOGENOM; HOG000008049; -.
DR   HOVERGEN; HBG050922; -.
DR   InParanoid; O75223; -.
DR   KO; K00682; -.
DR   OMA; RCPHSPM; -.
DR   OrthoDB; EOG091G0NMM; -.
DR   PhylomeDB; O75223; -.
DR   TreeFam; TF314378; -.
DR   BRENDA; 2.3.2.4; 2681.
DR   Reactome; R-HSA-174403; Glutathione synthesis and recycling.
DR   ChiTaRS; GGCT; human.
DR   EvolutionaryTrace; O75223; -.
DR   GenomeRNAi; 79017; -.
DR   PRO; PR:O75223; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000006625; -.
DR   CleanEx; HS_GGCT; -.
DR   ExpressionAtlas; O75223; baseline and differential.
DR   Genevisible; O75223; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0003839; F:gamma-glutamylcyclotransferase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0006750; P:glutathione biosynthetic process; TAS:Reactome.
DR   GO; GO:0001836; P:release of cytochrome c from mitochondria; IMP:UniProtKB.
DR   CDD; cd06661; GGCT_like; 1.
DR   InterPro; IPR017939; G-Glutamylcylcotransferase.
DR   InterPro; IPR013024; GGCT-like.
DR   PANTHER; PTHR12935; PTHR12935; 1.
DR   SUPFAM; SSF110857; SSF110857; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acyltransferase; Alternative splicing;
KW   Complete proteome; Phosphoprotein; Reference proteome; Transferase.
FT   CHAIN         1    188       Gamma-glutamylcyclotransferase.
FT                                /FTId=PRO_0000089580.
FT   REGION       19     24       Substrate binding.
FT                                {ECO:0000305|PubMed:18515354}.
FT   ACT_SITE     98     98       Proton acceptor.
FT                                {ECO:0000269|PubMed:18515354}.
FT   BINDING     139    139       Substrate. {ECO:0000305|PubMed:18515354}.
FT   MOD_RES     173    173       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D7X8}.
FT   VAR_SEQ      48    141       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_046463.
FT   VAR_SEQ      97    188       QEGVKSGMYVVIEVKVATQEGKEITCRSYLMTNYESAPPSP
FT                                QYKKIICMGAKENGLPLEYQEKLKAIEPNDYTGKVSEEIED
FT                                IIKKGETQTL -> WRKKRHTAFQNQGNHPCKHKTRMWDRD
FT                                PKIPVQNLSLALCWQAQSGHGTCNRLFAWVQKKMVCRWSIK
FT                                RS (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_046464.
FT   VAR_SEQ      97    114       QEGVKSGMYVVIEVKVAT -> LFAWVQKKMVCRWSIKRS
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_035599.
FT   VAR_SEQ     115    188       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_035600.
FT   MUTAGEN      23     23       G->A: Marked decrease in catalytic
FT                                efficiency.
FT                                {ECO:0000269|PubMed:18515354}.
FT   MUTAGEN      98     98       E->A,Q: Abolishes activity without
FT                                altering structure.
FT                                {ECO:0000269|PubMed:18515354}.
FT   MUTAGEN     105    105       Y->F: Marked decrease in catalytic
FT                                efficiency and specific activity.
FT                                {ECO:0000269|PubMed:18515354}.
FT   MUTAGEN     125    125       Y->F: Little or no change in reaction
FT                                kinetics. {ECO:0000269|PubMed:18515354}.
FT   STRAND       16     21       {ECO:0000244|PDB:3CRY}.
FT   HELIX        24     26       {ECO:0000244|PDB:3CRY}.
FT   HELIX        28     34       {ECO:0000244|PDB:3CRY}.
FT   STRAND       39     56       {ECO:0000244|PDB:3CRY}.
FT   TURN         62     64       {ECO:0000244|PDB:3CRY}.
FT   STRAND       68     87       {ECO:0000244|PDB:3CRY}.
FT   HELIX        88     90       {ECO:0000244|PDB:3CRY}.
FT   HELIX        91     97       {ECO:0000244|PDB:3CRY}.
FT   HELIX       100    102       {ECO:0000244|PDB:3CRY}.
FT   STRAND      106    114       {ECO:0000244|PDB:3CRY}.
FT   STRAND      119    126       {ECO:0000244|PDB:3CRY}.
FT   STRAND      128    132       {ECO:0000244|PDB:3CRY}.
FT   HELIX       137    149       {ECO:0000244|PDB:3CRY}.
FT   HELIX       154    161       {ECO:0000244|PDB:3CRY}.
FT   HELIX       174    181       {ECO:0000244|PDB:3CRY}.
SQ   SEQUENCE   188 AA;  21008 MW;  88B5C6F67F31C56C CRC64;
     MANSGCKDVT GPDEESFLYF AYGSNLLTER IHLRNPSAAF FCVARLQDFK LDFGNSQGKT
     SQTWHGGIAT IFQSPGDEVW GVVWKMNKSN LNSLDEQEGV KSGMYVVIEV KVATQEGKEI
     TCRSYLMTNY ESAPPSPQYK KIICMGAKEN GLPLEYQEKL KAIEPNDYTG KVSEEIEDII
     KKGETQTL
//
